Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertram, L.
Right arrow Articles by Tanzi, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertram, L.
Right arrow Articles by Tanzi, R. E.
NEUROLOGY 2004;62:304-306
© 2004 American Academy of Neurology


Brief Communications

PEN2 is not a genetic risk factor for Alzheimer’s disease in a large family sample

L. Bertram, MD, R. Menon, BS, K. Mullin, BS, M. Parkinson, BS, M. L. Bradley, BS, D. Blacker, MD ScD and R. E. Tanzi, PhD

From the Genetics and Aging Research Unit (Drs. Bertram and Tanzi, R. Menon, K. Mullin, M. Parkinson, and M.L. Bradley), Center for Aging, Genetics, and Neurodegeneration, Department of Neurology, and Gerontology Research Unit (Dr. Blacker), Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, and Department of Epidemiology (Dr. Blacker), Harvard School of Public Health, Boston, MA.

Address correspondence and reprint requests to Dr. R.E. Tanzi, Genetics and Aging Research Unit, Center for Aging, Genetics, and Neurodegeneration, CNY 114, 16 St., Charlestown, MA 02129; e-mail: tanzi{at}helix.mgh.harvard.edu

PEN2 is a reasonable Alzheimer’s disease (AD) candidate gene because it is a necessary component of the {gamma}-secretase complex that generates ß-amyloid peptide. Moreover, its gene (PEN2) maps to a highly significant linkage region on chromosome 19q13. Four common polymorphisms in PEN2 were tested for genetic association with AD in a large and carefully ascertained AD family sample (789 subjects from 202 nuclear families) using single-locus and haplotype-based analyses. These results do not suggest PEN2 to be a major AD risk factor.


Received July 1, 2003. Accepted in final form September 17, 2003.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the January 27 issue to find the title link for this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.